- Iflytek reported a net loss of 238.9 million yuan for the first half of 2025.
- This loss has decreased by 40% compared to the same period last year, when the loss was 400.7 million yuan.
- Revenue for Iflytek increased by 17% to 10.91 billion yuan compared to the previous year.
- The loss per share is 10.34 RMB cents, an improvement compared to last year’s 17.29 RMB cents loss per share.
- Current analyst ratings include 24 buy recommendations, 4 hold recommendations, and 1 sell recommendation.
- These figures are based on Iflytek’s own reported data.
A look at IFlytek Co Ltd A Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
IFlytek Co Ltd A, a company specializing in speech intelligence and artificial intelligence technology, is showing a promising long-term outlook according to the Smartkarma Smart Scores. With a Growth score of 3 and a Momentum score of 3, IFlytek Co Ltd A is positioned well for future expansion and market performance. Additionally, the company’s Value, Dividend, and Resilience scores are in the moderate range, indicating a stable foundation for potential growth in the coming years.
IFlytek Co Ltd A‘s focus on speech intelligence and AI, along with its diversified product offerings including chip products and software solutions, positions it favorably in the evolving tech market. With a balanced overall Smartkarma Smart Score, investors may view IFlytek Co Ltd A as a company with growth potential and resilience. This suggests that while not the highest-scoring in all areas, IFlytek Co Ltd A is a solid choice for investors looking for a company with a mix of growth, stability, and market momentum.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
